Banque Pictet & Cie Sa United Therapeutics Corp Transaction History
Banque Pictet & Cie Sa
- $17.1 Billion
- Q3 2025
A detailed history of Banque Pictet & Cie Sa transactions in United Therapeutics Corp stock. As of the latest transaction made, Banque Pictet & Cie Sa holds 4,778 shares of UTHR stock, worth $2.02 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,778Holding current value
$2.02 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
750Shares Held
43.4MCall Options Held
340KPut Options Held
318K-
Black Rock Inc. New York, NY5.47MShares$2.31 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.88 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$1 Billion12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$916 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$895 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $19.2B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...